Clinical Trial Update: Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing NUC-1031 plus cisplatin versus gemcitabine plus cisplatin in advanced biliary tract cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• NUC-1031

Snippet

Sponsor: NuCana plc | Conditions: Biliary Tract Cancer | Phase 3 | Status: TERMINATED | Results posted: 2023-05-24